At the heart of every high-quality innovative development lies a high-quality partnership. It has launched first platform in Ukraine for collaboration among biomedical researchers – BioGENext. The idea for BioGENext was born from a simple yet crucial need – to create a vibrant space for exchanging experience, knowledge, and innovative ideas in biomedicine and biopharmaceutical…
The full-scale war and the COVID-19 pandemic proved once again that the preservation of people’s lives depends on the availability of innovative solutions. Since 2015, the YURiA-PHARM Group has been developing a biotechnological R&D infrastructure YP Biotech, setting itself the goal of creating the first center in Ukraine, where a full cycle of biotechnological development…
On June 17-18, On June 17-18, Kyiv hosted a remarkable popular science event dedicated to science for the victory and reconstruction of Ukraine. Our R&D scientists of YURiA-PHARM had the opportunity to share their expertise in developing innovative mRNA-based vaccine solutions. mRNA vaccines revolutionized medicine. Why, what makes them so special? And how can we…
Together, we will continue scaling up our activities in the countries of Central Asia. The role of Reka-Med is a production site that will meet the demand for YURіА-PHARM products in the countries of Central Asia, and in Ukraine. The company will implement the system and quality standards of YURіА-PHARM, which will make it possible…
Umerox Inhal is an individual device designed for inhalation use of methoxyflurane. Low-dose methoxyflurane provide analgesia.
